Search research articles
Contact Us
Filters
Showing results (91-100 of 186) with videos related to
Page
of 19
Sort By:
Journal of Biological Regulators and Homeostatic Agents
|
January 3, 2014
Luteolin inhibits mast cell-mediated allergic inflammation
S K Kritas, A Saggini, G Varvara, et al.
International Journal of Immunopathology and Pharmacology
|
June 13, 2013
Vascular endothelial growth factor (VEGF), mast cells and inflammation
Y B Shaik-Dasthagirisaheb, G Varvara, G Murmura, et al.
International Journal of Immunopathology and Pharmacology
|
September 27, 2013
Impact of capsaicin on mast cell inflammation
S Frydas, G Varvara, G Murmura, et al.
Contemporary Clinical Trials
|
August 14, 2016
Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization
Katherine Y Fan, Aaron T Wild, Vivek G Halappa, et al.
Tumori
|
April 30, 1982
The outcome of Wilms' tumor in infants. Italy 1970-79
G Pastore, L Cordero di Montezemolo, A Brach del Prever, et al.
Journal of Biological Regulators and Homeostatic Agents
|
July 9, 2013
Role of vitamins D, E and C in immunity and inflammation
Y B Shaik-Dasthagirisaheb, G Varvara, G Murmura, et al.
Annals of Surgical Oncology
|
July 31, 2015
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience
Jingya Wang, Amol K Narang, Elizabeth A Sugar, et al.
Allergy
|
June 9, 2012
Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis
S Seshadri, D C Lin, M Rosati, et al.
Advances in Radiation Oncology
|
October 30, 2018
Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapy
Zhi Cheng, Lauren M Rosati, Linda Chen, et al.
Annals of Surgical Oncology
|
February 7, 2022
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
Colin S Hill, Lauren M Rosati, Chen Hu, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 186) with videos related to
Sort By:
Page
of 19
Journal of Biological Regulators and Homeostatic Agents
|
January 3, 2014
Luteolin inhibits mast cell-mediated allergic inflammation
S K Kritas, A Saggini, G Varvara, et al.
International Journal of Immunopathology and Pharmacology
|
June 13, 2013
Vascular endothelial growth factor (VEGF), mast cells and inflammation
Y B Shaik-Dasthagirisaheb, G Varvara, G Murmura, et al.
International Journal of Immunopathology and Pharmacology
|
September 27, 2013
Impact of capsaicin on mast cell inflammation
S Frydas, G Varvara, G Murmura, et al.
Contemporary Clinical Trials
|
August 14, 2016
Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization
Katherine Y Fan, Aaron T Wild, Vivek G Halappa, et al.
Tumori
|
April 30, 1982
The outcome of Wilms' tumor in infants. Italy 1970-79
G Pastore, L Cordero di Montezemolo, A Brach del Prever, et al.
Journal of Biological Regulators and Homeostatic Agents
|
July 9, 2013
Role of vitamins D, E and C in immunity and inflammation
Y B Shaik-Dasthagirisaheb, G Varvara, G Murmura, et al.
Annals of Surgical Oncology
|
July 31, 2015
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience
Jingya Wang, Amol K Narang, Elizabeth A Sugar, et al.
Allergy
|
June 9, 2012
Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis
S Seshadri, D C Lin, M Rosati, et al.
Advances in Radiation Oncology
|
October 30, 2018
Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapy
Zhi Cheng, Lauren M Rosati, Linda Chen, et al.
Annals of Surgical Oncology
|
February 7, 2022
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
Colin S Hill, Lauren M Rosati, Chen Hu, et al.
Page
of 19